Iron sucrose infusion in anaemic pregnant women and its outcome: A prospective study

Abstract

Objective: To evaluate the effect of intravenous iron sucrose complex in terms of improvement in haemoglobin status over 3 weeks following infusion in pregnant women diagnosed with Iron deficiency anaemia (IDA) and to know any immediate side effects of the therapy on maternal condition and on foetal condition. Methods: This study was conducted in all the pregnant women fulfilling the inclusion criteria who attended the OPD of the Department of Obstetrics and Gynaecology between 1/8/2017 and 31/10/2017. The Hb status of pregnant women who were diagnosed with anaemia was estimated by Sahli’s acid – haematin method and then Iron sucrose was given. Results: Initially the mean Hb status of the subjects was 6.159 +- 0.7510 gm %. In the first week following iron sucrose transfusion, there was a mean rise in the Hb status to 7.015+- 0.7576 gm%. The second week showed a further increase in the levels to 7.85 +-0.695 gm %. In the third week, the mean Hb status was found to be 8.625+-0.6606 gm%. The overall increase in the haemoglobin level was found to be significant. Conclusion: Intravenous iron sucrose transfusion is an effective treatment strategy for pregnant patients with anaemia during late pregnancy and in patients non-compliance to oral therapy.